Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome

Aerosol therapy in patients suffering from acute respiratory distress syndrome (ARDS) has so far failed in improving patients’ outcomes. This might be because dependent lung areas cannot be reached by conventional aerosols. Due to their physicochemical properties, semifluorinated alkanes (SFAs) coul...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Matthias Otto, Jörg Krebs, Peter Welker, René Holm, Manfred Thiel, Luciano Gattinoni, Michael Quintel, Charalambos Tsagogiorgas
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2021-03-01
coleção:	Pharmaceutics
Assuntos:	fluorocarbons aerosols drug carriers inhalation respiratory distress syndrome tissue distribution
Acesso em linha:	https://www.mdpi.com/1999-4923/13/3/431
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!